Kumar Namdev serves as the Global Head of CMC Product Development and Industrialization at Sanofi, specializing in mRNA drug product and process development. With a career spanning over two decades, Kumar has held several leadership roles at Sanofi, including Head of Global Specialty Care MSAT-Drug Substance and interim Head of Global MSAT, managing large teams and significant budgets to support the production of commercial biologics and pipeline products. Previous experience includes directorial positions at Novartis Vaccines & Diagnostics and Chiron, along with a role as Group Leader at CuraGen. Kumar's educational background includes a Ph.D. in Chemical Engineering from the University of Alberta and multiple degrees from the Indian Institute of Technology, Bombay.
This person is not in any teams
This person is not in any offices